{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T01:15:27Z","timestamp":1648948527634},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00117-021-00906-3","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:45:42Z","timestamp":1630709142000},"page":"1125-1128","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bilateraler Visusverlust bei Aderhautschwellung\u00a0\u2013 ab ins MRT!"],"prefix":"10.1007","volume":"61","author":[{"given":"Christian","family":"Steinke-Ramming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Schnober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Elling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Maus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"906_CR1","doi-asserted-by":"publisher","unstructured":"Hoyer A, Hamann V, B\u00f6hm AG, Pillunat LE (2007) Uveales Effusionssyndrom \u2013 Diagnose \u2013 Therapie \u2013 Verlauf. Klin Monbl Augenheilkd 224:V6. https:\/\/doi.org\/10.1055\/s-2007-992940","DOI":"10.1055\/s-2007-992940"},{"key":"906_CR2","doi-asserted-by":"publisher","unstructured":"Paulmann H, Heimann K (1977) Das Uveale Effusions-Syndrom. Periphere Retina. https:\/\/doi.org\/10.1007\/978-3-642-80489-2_88","DOI":"10.1007\/978-3-642-80489-2_88"},{"key":"906_CR3","doi-asserted-by":"publisher","unstructured":"Thomas M, Armenti ST, Ayres MB, Demirci H (2018) Uveal effusion after immune checkpoint inhibitor therapy. JAMA Ophthalmol 36(5):553\u2013556. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.0920","DOI":"10.1001\/jamaophthalmol.2018.0920"},{"key":"906_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13047_g","author":"K Katharina","year":"2016","unstructured":"K\u00e4hler KC, Hassel JC, Heinzerling L, Loquai C, M\u00f6ssner R, Ugurel S, Zimmer L, Gutzmer R, f\u00fcr das Komitee \u201eKutane Nebenwirkungen\u201c der Arbeitsgemeinschaft Dermatologische Onkologie (ADO): Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antik\u00f6rper beim metastasierten Melanom. JDDG 2016. https:\/\/doi.org\/10.1111\/ddg.13047_g","journal-title":"JDDG"},{"key":"906_CR5","doi-asserted-by":"publisher","unstructured":"Uyama M, Takahashi K, Kozaki J, Tagami N, Takada Y, Ohkuma H, Matsunaga H, Kimoto T, Nishimura T (2000) Uveal effusion syndrome\u2014Clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology 107(3):441\u20139. https:\/\/doi.org\/10.1016\/s0161-6420(99)00141-4","DOI":"10.1016\/s0161-6420(99)00141-4"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-021-00906-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00906-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:02:46Z","timestamp":1639137766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-021-00906-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s00117-021-00906-3","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"11 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Steinke-Ramming, G.\u00a0Schnober, M.\u00a0Elling und V.\u00a0Maus geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}